Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.4 % BTX opened at $1.80 on Friday. The company has a market cap of $105.59 million, a price-to-earnings ratio of -0.79 and […]
More Stories
Cantor Equity Partners, Inc. Class A Ordinary Shares Respond to Nomination of Howard W. Lutnick as U.S. Secretary of Commerce
Cantor Equity Partners, Inc. (NASDAQ:CEP) addressed recent developments on November 21, 2024, related to the nomination of Mr. Howard W....
Craig Scott Billings Sells 18,000 Shares of AppLovin Co. (NASDAQ:APP) Stock
AppLovin Co. (NASDAQ:APP – Get Free Report) Director Craig Scott Billings sold 18,000 shares of the business’s stock in a...
DiaSorin (OTCMKTS:DSRLF) Hits New 52-Week High – What’s Next?
DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Friday ....
Ibstock (LON:IBST) Stock Price Passes Below 50 Day Moving Average – Should You Sell?
Ibstock plc (LON:IBST – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock...
Templeton Emerging Markets Investment Trust (LON:TEM) Share Price Passes Below Fifty Day Moving Average – Time to Sell?
Templeton Emerging Markets Investment Trust plc (LON:TEM – Get Free Report)’s share price crossed below its 50-day moving average during...
Transat A.T. (TSE:TRZ) Stock Crosses Below 50 Day Moving Average – Here’s Why
Transat A.T. Inc. (TSE:TRZ – Get Free Report) crossed below its 50 day moving average during trading on Wednesday ....